Page last updated: 2024-11-05

ticlopidine and Diffuse Parenchymal Lung Disease

ticlopidine has been researched along with Diffuse Parenchymal Lung Disease in 2 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Research Excerpts

ExcerptRelevanceReference
"Ticlopidine treatment was stopped, and a prolonged course of prednisone was necessary to treat the pulmonary and intestinal symptoms."1.31Ticlopidine-induced interstitial pulmonary disease: a case report. ( Cornella, F; Kaeser, P; Persoz, CF; Rochat, T, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakamura, R1
Imamura, T1
Onitsuka, H1
Mishima, K1
Ishikawa, T1
Nagoshi, T1
Fujiura, Y1
Date, H1
Maeno, M1
Matsuo, T1
Koiwaya, Y1
Eto, T1
Persoz, CF1
Cornella, F1
Kaeser, P1
Rochat, T1

Other Studies

2 other studies available for ticlopidine and Diffuse Parenchymal Lung Disease

ArticleYear
Interstitial pneumonia induced by ticlopidine.
    Circulation journal : official journal of the Japanese Circulation Society, 2002, Volume: 66, Issue:8

    Topics: Aged; Anti-Inflammatory Agents; Female; Humans; Lung Diseases, Interstitial; Platelet Aggregation In

2002
Ticlopidine-induced interstitial pulmonary disease: a case report.
    Chest, 2001, Volume: 119, Issue:6

    Topics: Aged; Female; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Lung Diseases, Interstitial;

2001